2015
Is thrombin time too sensitive to dabigatran anticoagulation for clinical decision making in the setting of acute hemorrhage?
Siddon AJ, Rinder HM, Hendrickson JE, Tormey CA. Is thrombin time too sensitive to dabigatran anticoagulation for clinical decision making in the setting of acute hemorrhage? Annals Of Hematology 2015, 94: 1413-1414. PMID: 26027859, DOI: 10.1007/s00277-015-2406-z.Peer-Reviewed Original Research
2010
Evidence‐based practice guidelines for plasma transfusion
Roback JD, Caldwell S, Carson J, Davenport R, Drew MJ, Eder A, Fung M, Hamilton M, Hess JR, Luban N, Perkins JG, Sachais BS, Shander A, Silverman T, Snyder E, Tormey C, Waters J, Djulbegovic B. Evidence‐based practice guidelines for plasma transfusion. Transfusion 2010, 50: 1227-1239. PMID: 20345562, DOI: 10.1111/j.1537-2995.2010.02632.x.Peer-Reviewed Original ResearchMeSH KeywordsAnticoagulantsBlood Component TransfusionEvidence-Based MedicineHumansIntracranial HemorrhagesPlasmaWarfarinConceptsTransfusion of plasmaPlasma transfusionCommon clinical scenariosMassive transfusionEvidence-based guidanceSystematic reviewIntracranial hemorrhageTransfusion decisionsPractice guidelinesClinical scenariosRed blood cell ratioEvidence-based practice guidelinesMultidisciplinary guideline panelPlasma transfusion guidelinesBlood cell ratioGroup of patientsClinical practice guidelinesAppropriate transfusionTransfusion guidelinesWarfarin anticoagulationGRADE methodologyGuideline panelObservational studyTransfusionDefinitive guidelines